These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 33369089)
1. Prices of combination medicines and single-molecule antihypertensive medicines in India's private health care sector. Negi S; Neupane D; Sahoo SK; Mahajan T; Swaroop K; Moran AE; Sharma B; Pathni AK J Clin Hypertens (Greenwich); 2021 Apr; 23(4):738-743. PubMed ID: 33369089 [TBL] [Abstract][Full Text] [Related]
2. Research Letter: Antihypertensive Drugs Market in India: An Insight on Size, Trends, and Prescribing Preferences in the Private Health Sector, 2016-2018. Sahoo SK; Pathni AK; Krishna A; Moran AE; Cohn J; Bhatia S; Maheshwari N; Sharma B Glob Heart; 2021; 16(1):51. PubMed ID: 34381673 [TBL] [Abstract][Full Text] [Related]
3. Prices & availability of common medicines at six sites in India using a standard methodology. Kotwani A; Ewen M; Dey D; Iyer S; Lakshmi PK; Patel A; Raman K; Singhal GL; Thawani V; Tripathi S; Laing R Indian J Med Res; 2007 May; 125(5):645-54. PubMed ID: 17642500 [TBL] [Abstract][Full Text] [Related]
4. Where are we now: assessing the price, availability and affordability of essential medicines in Delhi as India plans free medicine for all. Kotwani A BMC Health Serv Res; 2013 Jul; 13():285. PubMed ID: 23885985 [TBL] [Abstract][Full Text] [Related]
5. Availability, price and affordability of essential medicines for managing cardiovascular diseases and diabetes: a statewide survey in Kerala, India. Satheesh G; Sharma A; Puthean S; Ansil T P M; E J; Raj Mishra S; Unnikrishnan MK Trop Med Int Health; 2020 Dec; 25(12):1467-1479. PubMed ID: 32959441 [TBL] [Abstract][Full Text] [Related]
6. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China. Fang Y; Wagner AK; Yang S; Jiang M; Zhang F; Ross-Degnan D Lancet Glob Health; 2013 Oct; 1(4):e227-37. PubMed ID: 25104348 [TBL] [Abstract][Full Text] [Related]
7. Pricing and availability of some essential child specific medicines in Odisha. Swain TR; Rath B; Dehury S; Tarai A; Das P; Samal R; Samal S; Nayak H Indian J Pharmacol; 2015; 47(5):496-501. PubMed ID: 26600637 [TBL] [Abstract][Full Text] [Related]
8. Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China. Yang H; Dib HH; Zhu M; Qi G; Zhang X Health Policy Plan; 2010 May; 25(3):219-29. PubMed ID: 19955093 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology. Saeed A; Saeed H; Saleem Z; Fang Y; Babar ZU PLoS One; 2019; 14(4):e0216122. PubMed ID: 31022276 [TBL] [Abstract][Full Text] [Related]
10. Assessing the prices and affordability of oncology medicines for three common cancers within the private sector of South Africa. Mattila PO; Babar ZU; Suleman F BMC Health Serv Res; 2021 Jul; 21(1):661. PubMed ID: 34229693 [TBL] [Abstract][Full Text] [Related]
11. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability. Husain MJ; Datta BK; Kostova D; Joseph KT; Asma S; Richter P; Jaffe MG; Kishore SP J Am Heart Assoc; 2020 May; 9(9):e015302. PubMed ID: 32338557 [TBL] [Abstract][Full Text] [Related]
12. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases. Ewen M; Zweekhorst M; Regeer B; Laing R PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413 [TBL] [Abstract][Full Text] [Related]
13. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Cameron A; Ewen M; Ross-Degnan D; Ball D; Laing R Lancet; 2009 Jan; 373(9659):240-9. PubMed ID: 19042012 [TBL] [Abstract][Full Text] [Related]
14. Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia. Babar ZU; Ibrahim MI; Singh H; Bukahri NI; Creese A PLoS Med; 2007 Mar; 4(3):e82. PubMed ID: 17388660 [TBL] [Abstract][Full Text] [Related]
15. Availability, prices and affordability of essential medicines for treatment of diabetes and hypertension in private pharmacies in Zambia. Kaiser AH; Hehman L; Forsberg BC; Simangolwa WM; Sundewall J PLoS One; 2019; 14(12):e0226169. PubMed ID: 31834889 [TBL] [Abstract][Full Text] [Related]
16. Availability, prices and affordability of essential medicines for children: a cross-sectional survey in Jiangsu Province, China. Sun X; Wei J; Yao Y; Chen Q; You D; Xu X; Dai J; Yao Y; Sheng J; Li X BMJ Open; 2018 Oct; 8(10):e023646. PubMed ID: 30341137 [TBL] [Abstract][Full Text] [Related]
17. Prices, availability and affordability of medicines in Rwanda. Bizimana T; Kayumba PC; Heide L PLoS One; 2020; 15(8):e0236411. PubMed ID: 32745100 [TBL] [Abstract][Full Text] [Related]
18. Price, availability and affordability of medicines. Mhlanga BS; Suleman F Afr J Prim Health Care Fam Med; 2014 Jun; 6(1):E1-6. PubMed ID: 26245401 [TBL] [Abstract][Full Text] [Related]
19. The prices people pay for medicines in Zimbabwe. Gavaza P; Simoyi T; Makunike B; Maponga CC Cent Afr J Med; 2009; 55(1-4):14-9. PubMed ID: 21977842 [TBL] [Abstract][Full Text] [Related]
20. Access and Affordability of Medicines in Malaysia: Need for a National Pricing Policy. Wong SL; Ibrahim S; Abdul Kadir N; Mohd Salleh S Appl Health Econ Health Policy; 2019 Oct; 17(5):641-654. PubMed ID: 31093937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]